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use disorder and delinquent behavior: a
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Abstract
Purpose: Systemic family interventions have shown to be effective in adolescents with substance use disorder and
delinquent behavior. The interventions target interactions between the adolescent and involved systems (i.e. youth,
family, peers, neighbors, school, work, and society). Next to effectiveness considerations, economic aspects have gained
attention. However, conventional generic quality of life measures used in health economic evaluations may not be
able to capture the broad effects of systemic interventions. This study aims to identify existing outcome measures,
which capture the broad effects of systemic family interventions, and allow use in a health economic framework.
Methods: We based our systematic review on clinical studies in the field. Our goal was to identify effectiveness studies
of psychosocial interventions for adolescents with substance use disorder and delinquent behavior and to distill the
instruments used in these studies to measure effects. Searched databases were PubMed, Education Resource
Information Center (ERIC), Cochrane and Psychnet (PsycBOOKSc, PsycCRITIQUES, print). Identified instruments were
ranked according to the number of systems covered (comprehensiveness). In addition, their use for health economic
analyses was evaluated according to suitability characteristics such as brevity, accessibility, psychometric properties, etc.
Results: One thousand three hundred seventy-eight articles were found and screened for eligibility. Eighty articles
were selected, 8 instruments were identified covering 5 or more systems.
Conclusions: The systematic review identified instruments from the clinical field suitable to evaluate systemic family
interventions in a health economic framework. None of them had preference-weights available. Hence, a next step
could be to attach preference-weights to one of the identified instruments to allow health economic evaluations of
systemic family interventions.
Keywords: Economic evaluation, Instrument, Externalizing, Mental health, Youth
Background
Systemic family interventions are psychotherapeutic
treatments, which are increasingly used to treat children
and adolescents with mental disorders. These interven-
tions are based on the idea that the behavior of a patient
is the result of interactions between himself and the
different ‘systems’ he is involved in (i.e. family, peers,
school, etc.) and of the interactions between these
systems [1–3]. Treatment is directed at improving the
disturbing aspects within these interactions [3] and it
actively involves the systemic context of the patient.
Hence, potential effects are broad and may range from
improvements in the interactions with parents, other
family members, peers or neighbors, to improvements in
educational achievements and work relations, reduction
of criminal activity and substance use and reduction of
* Correspondence: schawo@bmg.eur.nl
1Institute for Medical Technology Assessment & Institute of Health Policy &
Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR
Rotterdam, The Netherlands
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Schawo et al. Health and Quality of Life Outcomes  (2017) 15:179 
DOI 10.1186/s12955-017-0722-9
problems with the juvenile justice system [2, 4–6].
Systemic family interventions have shown particularly
effective in the treatment of adolescents with substance
use disorders and delinquency [7–10]. Examples of these
interventions are Multisystemic Therapy (MST), Functional
Family Therapy (FFT), Multidimensional Family Therapy
(MDFT) and Brief Strategic Family Therapy (BSFT) [7–10].
With the increasing use of systemic family interven-
tions, the question of funding and reimbursement arises.
In some countries, like the Netherlands or the United
Kingdom, systemic family interventions are reimbursed
from social health insurance schemes and, as such, are
part of collectively financed health care. Hence, the in-
terventions compete for limited funds with other health
care expenditures and, on top of proving effective, need
to demonstrate value for money. Common practice in
the economic evaluation of medical interventions is the
use of cost-utility analysis (CUA) [11, 12] measuring ef-
fects in terms of Quality-Adjusted Life-Years (QALYs).
QALYs combine length and quality of life gained. Typic-
ally, quality of life is measured through preference-
based, generic health outcome measures (such as the
EQ-5D). These outcome measures typically concentrate
on improvements in a number of health domains. A re-
cent publication of our department [13] described the
results of a CUA of MDFT versus Cognitive Behavioral
Therapy (CBT) in which the effects were measured with
the EQ-5D. Yet, in the field of mental health, doubts
have been expressed [14, 15] on the use of these generic
quality of life measures [16] as these tools might be too
limited to cover all relevant treatment effects. Studies on
the applicability of these measures in mental health have
presented mixed results [14, 15]. Furthermore, there is
increasing attention for the inclusion of spillover effects
on caregivers and families in economic evaluations. Cur-
rently, these effects are not yet included [17, 18], though
they may be particularly important in treatment of
younger patients. Recently, the Second Panel of Cost-
Effectiveness in Health and Medicine has recom-
mended further research on quality of life effects on
family members of patients [19].
Both aspects, the assessment of effects specific to men-
tal health treatments and the inclusion of (partial) effects
on third parties, seem of particular relevance to the eco-
nomic evaluation of systemic interventions in delinquency
and substance use in adolescents. As outcomes of sys-
temic family interventions are broad and transcend health
gains, conventional CUA outcome measures may be too
limited and insufficiently connected to clinical practice.
This may be one of the reasons why economic evaluations
of systemic interventions are still scarce and overall of low
quality [20]. Existing economic evaluations of these in-
terventions vary in setting, design and in outcomes
measured [20] hence limiting the comparability of
results. Furthermore, few studies consider effects on
others than the patient [1].
If the aim is to perform economic evaluations of sys-
temic family interventions which account for all relevant
effects, a disorder-specific multidimensional measure that
captures all relevant systemic contexts would be desirable.
Ideally, if such a measure had societal preference-weights
attached to its dimensions and levels, it would deviate
from the common CUA methodology yet enable CUA-
like economic evaluations. In patients with substance use
disorder (one of the patient groups treated with systemic
family interventions), the need for such a single compre-
hensive outcome measure capturing the full benefits of
treatments has been recognized before [21]. Deas and
Thomas [22] and Hogue and Liddle [23] emphasized
the necessity of assessing various outcomes beyond ef-
fects in the adolescent. In an illustrative pilot study,
Jofre-Bonet and Sindelar [21] presented a first example
of a preference-based measure for adult populations
with substance abuse. However, that measure was not
based on standard preference-elicitation techniques but
the authors attached patient preference-weights to the
eight main domains of the Addiction Severity Index
(ASI) [24] by constructing a weight index.
In the current study, we take this line of research
further by searching for a multidimensional outcome
measure to evaluate systemic family interventions in the
populations of adolescents with substance abuse disorder
or problems of delinquency. Such a measure could facili-
tate CUAs of systemic family interventions and could ei-
ther be based on existing effectiveness measures in this
field or fully designed anew. In both cases, the use of an
existing measure or the design of a new measure, relevant
domains would need to be identified. Based on consult-
ation of the literature on systemic family interventions [1,
25, 26] the domains relating to aspects of the individual
patient, family, school (or work) and other community en-
vironments (e.g. peers, neighbors) were considered most
relevant to the evaluation of the interventions. Figure 1
provides a graphical illustration of these domains, which
indicate where potential effects may occur. The strength
of the impact on the different systems may obviously dif-
fer, depending on the exact underlying problems and
other contextual factors.
We perform a systematic literature review to investi-
gate and appraise available instruments in the field of
adolescent delinquency and substance use, which cover
the relevant domains and which are already accepted
and validated in the field. We assess which of these in-
struments might be most suited to serve as a basis for a
preference-based measure in CUA, based on characteris-
tics like comprehensiveness, brevity, accessibility, psy-
chometric properties, etc. Advantage of using an existing
instrument would be its being established, accepted and
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validated in the field and known by clinicians. It would
then only be necessary to add preference-weights to the
domains to account for differences in impact of each
domain. In this way we aim to contribute to the devel-
opment of adequate outcome measures to assess the
economic value of systemic family interventions in the
treatment of delinquency and substance use.
Methods
We conducted a systematic literature review to identify
instruments within the effectiveness and efficacy litera-
ture of mental health interventions for adolescents with
substance use disorder and delinquency problems. We
then assessed the suitability of these instruments for use
of preference elicitation techniques. The assessment was
based on several characteristics relevant to attain societal
preference weights. These characteristics were among
others the coverage of the systems displayed in Fig. 1
(i.e. youth, family, peers, school, work, society and neigh-
bors), brevity, practicability of use, accessibility, psycho-
metric properties and acceptance in the field. The review
protocol was not registered. Yet, this study adhered to the
PRISMA reporting guidelines [27].
Criteria for inclusion
Types of participants
The target population of the systematic literature review
consisted of adolescents between 12 and 18 years of age
with symptoms of delinquency and/or substance use. Pa-
tients from specific sub-groups (e.g. homeless or runaway
adolescents or adolescents with substance use disorder
and comorbid depression) were excluded. As studies fo-
cusing on these subgroups evaluated specific outcomes,
which were not necessarily relevant for the entire popu-
lation of adolescents with substance use disorders and
delinquent behavior, these studies were not considered
relevant for the current study.
Types of interventions
We included studies on various mental health inter-
ventions for adolescents with substance use disorder
or delinquency in a therapy/counseling setting in the
systematic search to cover as many instruments as
possible in the relevant target population. Individual
interventions as well as systemic family interventions
were included. Examples of such interventions are
Cognitive Behavioral Therapy (CBT), Motivational En-
hancement Therapy (MET), Multidimensional Family
Therapy (MDFT), Multi Systemic Therapy (MST),
Functional Family Therapy (FFT) and Ecologically
Based Family Therapy (EBFT). Two types of interven-
tions were excluded. First, interventions in mental
health care that consisted of only pharmacotherapy
were excluded since the focus of our study was specif-
ically on the effect of psychosocial interventions. Sec-
ond, mental health interventions for the prevention of
criminal behavior or substance use disorder were ex-
cluded, as the symptoms within this group (i.e. high
risk behavior or general behavioral problems) were not
considered severe enough to fit the definition of the
target population.
Types of outcome measures
Our objective was to identify a wide array of instruments
used to measure the effect of mental health interven-
tions for adolescents with substance use disorders and
delinquent behavior. Hence, we included studies with all
measures of effectiveness and treatment outcome as well
as efficacy studies.
Search methods for identification of studies
Databases were selected as to cover both interventions
in the medical and in the educational field. The system-
atic literature review was performed in PubMed, Psy-
chnet (PsycBOOKSc, PsycCRITIQUES, print), Cochrane
and ERIC (Education Resource Information Center) to
identify all effectiveness studies of mental health inter-
ventions for adolescent with substance use disorder or
problems of delinquency. The databases were consulted
between 5 March 2013 and 8 March 2013. Additional
studies were identified based on reference list search.
There were no restrictions on the type of publication.
The language of publication was required to be English
youth
family
peers
school
work
neighbors
society
Fig. 1 Systems involved in systemic family interventions for
treatment of delinquency and substance-abuse in adolescents
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and publication date was 1990 or more recent. The
search strategy used is displayed below.
Data analysis
Study selection
First, duplicates were removed. Then, the study selec-
tion was performed in two rounds. First, a selection
based on title and abstract was performed, then se-
lected articles were subject to a second screening
based on full texts. Both rounds of selection were per-
formed by two researchers independently and were
each followed by a round of consensus. The eligibility
criteria for the first selection based on title and
abstract were the following.
Subsequently, when abstracts or titles adhered to the
above screening criteria, full texts were independently
screened for inclusion based on the following (additional)
criteria.
Furthermore, articles from reference lists of reviews
were identified. For these, we performed a shortened
screening and selection procedure. Titles of these arti-
cles were screened based on the following criteria:
a) > =1990; b) peer-reviewed article; c) randomized
control trial or effect/effectiveness/efficacy study/treat-
ment outcome; d) adolescents; e) delinquency/
offenders/substance-abuse; f ) mental health interven-
tion (no pharmacotherapy). If this selection resulted in
inclusion, the abstract was screened and a final decision
on inclusion or exclusion was made. Included articles
were added to the database of identified articles for fur-
ther data synthesis.
Data extraction
Data extraction was performed in MS Access with prede-
fined fields. From all selected studies, general information,
such as the title of the study, the name of the author, jour-
nal, etc., were recorded, as well as information on the
sample size, the studied population and type of interven-
tion (systemic, other [i.e. individual, group intervention],
both).
In addition to this general information, instrument-
specific information was extracted. This information
consisted of instrument names (e.g. Child Behavior
Checklist [CBCL]) and covered domains (e.g. family
functioning, adolescent behavior, etc.). This information
was recorded in order to identify the instruments cur-
rently used in the field and their coverage of the differ-
ent systems relevant for the evaluation of systemic
family interventions (Fig. 1).
Synthesis and evaluation of results
As a next step, domain names of the instruments were
extracted from the identified articles and linked to the
systems relevant for the evaluation of systemic family in-
terventions (Fig. 1): youth, family, peers, school, work,
society and neighbors. Domain names were verified with
available resources such as guidelines, websites of the
developer and other articles using the same instrument.
After verification, the domains were translated into the
systems mentioned in Fig. 1. For this purpose, domains
related to the adolescents themselves, such as ‘substance
use and abuse’, ‘physical health’ or ‘mental health’ were
linked to the system ‘youth’ whereas domains such as ‘fam-
ily relations’ were recoded into the system ‘family’, domains
like ‘peer relations’, ‘social skills’ or ‘leisure/recreation’ were
labeled as ‘peer’ system, domains like ‘educational status’
were labeled ‘school’ and ‘delinquency’ as ‘society’. Table 1
provides an example of the process of recoding for the
Problem Oriented Screening Instrument for Teenagers
(POSIT). Next, all instruments were classified based on the
number of systems (presented in Fig. 1) covered and
ranked from highest to lowest. Those covering five or more
systems were considered most relevant for our purpose as
those covered the majority of effects of systemic family in-
terventions in adolescents with substance use disorder or
problems of delinquency.
In line with our aim to identify an instrument, which
captures most of the systems relevant to the evaluation
of systemic family interventions, those instruments
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covering more than five systems were evaluated in more
detail. These were then appraised according to necessarily
arbitrary characteristics of brevity, feasibility, practicability,
accessibility, psychometric properties and acceptance in the
field. These characteristics were set up as to identify one or
more instruments suitable to attain societal preference-
weights for an instrument by means of preference-
elicitation techniques. Within preference-elicitation tech-
niques, such as discrete choice experiments, the number of
domains rarely exceeds ten [28, 29]. With higher numbers
of domains, the decision task may become too complex
and cognitively demanding for the respondent [28]. Hence,
a suitable instrument should possess less than 10 domains.
A second consideration was the practical use of the instru-
ment itself in clients. An instrument, ideally suitable for
self-completion, should put as little strain as possible on
the respondent, without loss of important content. Hence,
we set a limit to the maximum number of items of the in-
strument at 500 and a maximum completion time of 1 h,
assuming that these would be reasonable amounts of items
and time to ask from respondents. Another criterion was
the accessibility of the instrument as to ascertain ease of
use in future studies. Evaluation of this criterion included
the price of use and availability of a (digital) version. Psy-
chometric properties were considered to judge the suitabil-
ity of the instrument for integration in health economic
evaluations. Findings from existing publications on validity
and reliability of the instruments were considered in this
context. Finally, the frequency of use of the instrument was
considered an indicator for the acceptance of the instru-
ment in the clinical field. This was approximated by the
number of times that an instrument was used in the studies
identified in this review.
Results
Study selection
The systematic search resulted in 1060 articles. After du-
plicates were removed 1002 articles remained. Screening
based on abstracts resulted in the exclusion of 880 arti-
cles. Full text assessment of the remaining 122 articles
resulted in the exclusion of two articles not matching
the definition of the intervention, 23 articles not match-
ing the disease or symptoms of the target population, 13
not matching the requirements for the principle outcome
of the studies, and 9 due to unavailability of a full text ver-
sion. Hence 75 articles were included. Furthermore, 318
underlying articles from reviews were screened. From
these, 166 articles remained after duplications with the
first search results were removed. The screening of these
articles in a first round by title and in a second round by
title and abstract resulted in the exclusion of 161 articles
and inclusion of five additional publications (Fig. 2).
Study results
A total of 80 articles were included in the synthesis. The
aim was to identify clinical instruments in the field suit-
able for integration in a health-economic framework
based on criteria of coverage of relevant systems, feasibil-
ity to perform preference-elicitation techniques, practic-
ability of use, accessibility for future studies, psychometric
properties and acceptance in the field. A summary of the
identified reviews and clinical trials is provided in Tables 2
and 3 respectively. From the 80 selected articles we identi-
fied a total of 102 instruments, differing substantially in
what these intended to measure and in whom. These in-
struments measured varying (combinations of) outcomes
such as substance use, physical health, mental health, fam-
ily relations, peer relations, school and work status and
criminal history.
Instrument suitability for evaluation of systemic family
interventions
Table 4 displays the instruments ranked according to the
number of systems covered.
The majority, 81 instruments, covered just one system
such as the youth or the family system. These one-
dimensional instruments were often used in a multi-
method (i.e. a combination of self-report, parent-report,
court records, urine-analysis, etc.) assessment battery of
instruments. Fourteen instruments covered two, three or
four systems. We identified eight instruments, which
covered five or more systems and which therefore were
considered potentially suitable for comprehensive evalu-
ation of systemic family interventions.
Detailed information on these eight instruments was
searched and is highlighted below. It has to be noted
that available information per instrument (e.g. number
of items, example questions, domain names, most recent
versions of the instrument, type of administration, etc.)
strongly differed.
The Adolescent Drug Abuse Diagnosis (ADAD) [30]
is a multidimensional instrument to evaluate adolescent
Table 1 Example of recoding of domains into systems
Problem Oriented Screening Instrument for Teenagers (POSIT)
Domain Corresponding system
Substance use and abuse youth
Physical health youth
Mental health youth
Family relations family
Peer relations peers
Educational status school
Vocational status work
Social skills peers
Leisure/recreation peers,
Aggressive behavior/delinquency society
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substance use [31] administered in a structured interview.
It covers nine problem areas: medical, school, employment,
social relations, family and background relations, psycho-
logical, legal, alcohol use, and drug use [32]. Example ques-
tions are “How would you rate your overall physical
health?”, “How many days in the past 30 have you been ab-
sent (from school)?” and “How many months did you work
fulltime in the past six months?”. A patient’s treatment
need is assessed by the interviewer per problem area based
on a 10-point rating scale with scores 0–1 (no real
Fig. 2 Phases of the systematic review adapted from Moher et al. [27]
Table 2 List of identified reviews
ID Authors Year Population
1 Armelius Bengt-Åke, Andreassen Tore Henning 2007 youth with antisocial behavior
2 Baldwin SA, Christian S, Berkeljon A, Shadish WR. 2011 adolescent delinquents and substance-abusers
3 Borduin CM. 1999 criminal and violent adolescents
4 Brown SA, D'Amico EJ. 2003 adolescent substance abusers
5 Cottrell D, Boston P. 2002 patients with conduct and attention deficit disorders, substance misuse, etc.
6 Curtis N, Ronan K, Borduin C M 2004 antisocial youths and youths with serious emotional disturbances
7 Deas D, Thomas SE. 2001 adolescents with substance use disorders
8 Deas D. 2007 adolescents with AOD disorders
9 Diamond G, Josephson A. 2005 adolescent substance use
10 Ferguson LM, Wormith JS. 2012 (adult and) young offenders
11 Henggeler SW, Sheidow AJ. 2012 conduct disorder and delinquency in adolescents
12 Henggeler SW, Sheidow AJ. 2003 conduct disorder and delinquency in adolescents
13 Hogue A, Liddle HA. 2009 adolescent substance abuse
14 Littell Julia H, Campbell Margo, Green Stacy, Toews Barbara 2005 (among others) delinquent youth
15 Randall J, Cunningham PB. 2003 violent substance-abusing and substance-dependent juvenile offenders
16 Tanner-Smith EE, Wilson SJ, Lipsey MW. 2013 adolescent substance use disorder
17 Tripodi SJ, Bender K, Litschge C, Vaughn MG. 2010 adolescent alcohol use
18 Waldron HB, Kaminer Y. 2004 adolescent substance use disorders
19 Waldron HB, Turner CW. 2008 adolescent substance abuse
20 Walker D F, McGovern S K, Poey E L, Otis K E 2004 adolescent sexual offenders
21 Woolfenden Susan, Williams Katrina J, Peat Jennifer 2001 adolescents with delinquency or conduct disorder
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problem), 2–3 (slight problem, treatment probably not ne-
cessary), 4–5 (moderate problem, some treatment indica-
tion), 6–7 (considerable problem, treatment necessary),
and 8–9 (extreme problem, treatment absolutely neces-
sary) [32]. The instrument consists of 150 items and is
based on the Addiction Severity Index (ASI) [24]. There is
also a European version of the instrument, the European
Adolescent Assessment Dialogue (EuroADAD). Its aim is
to “describe, communicate and compare young clients
over borders of countries and institutions.” [33].
The Adolescent Diagnostic Interview (ADI) [34]
originated in the 1980’s as a project “to address measure-
ment gaps in the alcohol-drug field” [35]. It is a tool to
measure substance use disorders in adolescents “…orga-
nized around DSM–III–R criteria for psychoactive sub-
stance use disorders.” [34]. In the literature a version
based on DSM-IV criteria is also mentioned [36]. The
instrument is administered in a structural interview set-
ting. Substance use of the adolescent is assessed based
on two main sections with each two subsections: clinical
(sociodemographics, psychosocial stressors, substance
use frequency and duration, alcohol symptoms, cannabis
symptoms, other substance symptoms and level func-
tioning) and appendix (orientation and memory screen)
[34]. Example items are “Which drugs have you used five
or more times in your life?”, “How many times do you
think that you have used (this drug/each drug) in the
past 6 months?”, “Have you ever continuously felt like
crying for several days in a row?” [36]. A computer-
based version is available for self-assessment [34].
The Child Adolescent Functional Assessment Scale
(CAFAS) “…assesses the degree of impairment in func-
tioning in children and adolescents secondary to emo-
tional, behavioral, or substance use problems” [37]. The
instrument originally included seven scales, of which five
evaluated the functioning of the youth and two scales
assessed the environment of the youth [37]. The five
youth scales were role performance, thinking, behavior
towards self and others, moods/emotions, and substance
use [37]. The two environment scales were basic needs
and family/social support. The scales subsequently have
been changed and expanded to 8 youth and 2 caregiver
scales: school, home, community, behavior towards others,
moods, self-harm, substance use, and thinking (youth)
and material needs, and social support (caregiver) [38].
The different subscales include items of four severity
levels (i.e. severe, moderate, mild, and minimal or no
impairment) [37]. The assessor determines the level of
Table 4 Ranking of instruments according to the number of systems covered
Name instrument # systems covered Systems
youth family peers school work society neighbors
POSIT 6 ● ● ● ● ● ●
CAFAS 6 ● ● ● ● ● ●
WAJCA-RA 6 ● ● ● ● ● ●
ADAD 6 ● ● ● ● ● ●
T-ASI 6 ● ● ● ● ● ●
CTRADA 5 ● ● ● ● ●
ADI 5 ● ● ● ● ●
GAIN 5 ● ● ● ● ●
PEI 4 ● ● ● ●
MAAS 4 ● ● ● ●
FES 4 ● ● ● ●
CPHHQ 3 ● ● ●
FFS 3 ● ● ●
SCQ 3 ● ● ●
SRD 2 ● ●
SCL-90-R 2 ● ●
BSI 2 ● ●
Hollinghead classification system 2 ● ●
IPPA 2 ● ●
CRI 2 ● ●
MAP 2 ● ●
Note. • = system covered by instrument
Schawo et al. Health and Quality of Life Outcomes  (2017) 15:179 Page 11 of 19
problems of the patient per subscale. He first considers
the items of the most severe level, checks whether these
items apply and if not progresses towards the lesser symp-
tom levels until an item of the current severity level ap-
plies to the patient [37]. Then scores of 30, 20, 10 and 0
are applied to severity levels severe, moderate, mild and
minimal respectively such that an overall severity rating is
generated. Overall ratings range from 0 to 240 with higher
scores indicating higher severity [30].
The Global Appraisal of Individual Needs (GAIN)
questionnaire [39] is a collection of related instruments that
are gathered under the umbrella of GAIN using an identical
format. The most recent version of the questionnaire has
been adapted for use in adults as well as adolescents. The
GAIN is an assessment measure, which can be used in
several settings and populations such as inpatient, outpatient
short- or long-term treatment evaluation, legal programs or
school-based programs [40]. It assesses eight domains: back-
ground, substance use, physical health, risk behaviors, men-
tal health, environment, legal, and vocational. Example
items of the GAIN are “During the past 90 days, on how
many days were you in foster care?”, “When was the last
time, if ever, you used...any kind of alcohol?”, and “What
was the most (drinks/joints/etc.) you had in one day?” [41].
The Problem Oriented Screening Instrument for
Teenagers (POSIT) is a screening instrument for ado-
lescents with substance use disorder, which was designed
as a component of the Adolescent Assessment/Referral
System (AARS) [42]. It “is designed to flag those func-
tional areas, if any, where a problem MAY exist that re-
quires further assessment and perhaps treatment.” [42].
The instrument addresses ten functional domains: sub-
stance use/abuse, physical health status, mental health
status, family relations, peer relations, educational status,
vocational status, social skills, leisure and recreation, and
aggressive behavior and delinquency. The POSIT in-
cludes 139 items, which can be answered with yes or no
[42]. Per domain, items can be grouped into three categor-
ies: general purpose items, general purpose age-related
items, and red flag items [42]. Each affirmative response
to a general purpose item counts as one point towards the
total functional domain score [42]. The same holds for
general purpose age-related items, but these are only rele-
vant for specific age groups of respondents (below or
above 16 years) [42]. Red flag items indicate the need for
treatment once one of these items is answered positively
[42]. Example items of the POSIT are “Do you get into
trouble because you use drugs or alcohol at school?”, “Do
your parents or guardians argue a lot?”, and “Have you
ever been told you are hyperactive?” [42].
The Teen Addiction Severity Index (T-ASI) [43] is
the adolescent version of the ASI [24]. The instrument
assesses seven dimensions of functioning (i.e. alcohol
and drug use, school status, employment-support status,
family relationships, legal status, peer-social relation-
ships, and psychiatric status) [43]. The T-ASI is intended
for use in adolescents with substance use disorder aged
between 12 and 19 years [43]. Example items of the T-
ASI are “What chemicals have you used in the past
month?”, “School days spent in detention or any other
measures taken for disciplinary reasons last month.
(Principal's or school counselor's office.)”, and “How
long was your longest period of employment during
the past year?” [44]. Responses are rated on a 5-point
scale [43]. A revised version of the T-ASI, the T-ASI-2
has been developed in 2008. This concerns a version of
the instrument, which is self-administered via computer
or telephone and contains additional domains [45].
The WAJCA-RA structured interview is a risk as-
sessment tool for juvenile offenders developed by the
Washington State Institute for Public Policy in collabor-
ation with the juvenile courts [46]. It was designed to iden-
tify risk and protective factors in the following domains:
criminal history, school, use of free time, employment,
relationships, family, alcohol and drugs, mental health,
attitudes, social skills, progress on community supervi-
sion, progress while confined [46]. Example items of
the WAJCA-RA are “Violence/anger: Reports of dis-
playing a weapon, fighting, threatening people, violent
outbursts, violent temper, fire starting, animal cruelty,
destructiveness, volatility, intense reactions.”, “Runaways
or times kicked out of home”, and “Number of weeks of
longest period of employment” [46].
The Parent and adolescent interview CTRADA that
was used by Liddle et al. [47] was not considered a com-
mon instrument but institution-specific interview as no
references could be retrieved from neither literature nor
the Internet. The instrument therefore could not be fur-
ther considered or assessed.
Instrument suitability for use in CUA
Hence seven instruments remained for further consider-
ation. The frequency of use of each of these instruments
in the identified studies is presented in Table 5. Further-
more, Table 6 illustrates an evaluation of the instruments
for suitability for use in CUA and use of preference elicit-
ation techniques. When our feasibility characteristics were
applied to the seven instruments, three instruments
(POSIT, WAJCA, ADI) were excluded due to the number
of domains exceeding ten, and one instrument (GAIN)
was excluded due to reasons of practicability (i.e. number
of items exceeding the maximum of 500 and completing
time exceeding 1 h). It was noted that a short version of
the GAIN (Global Appraisal of Individual Needs Short
Screener, GAIN-SS) is available as well [48]. However,
based on its goals of screening, use for clinical staff with
limited experience or periodic measurement [48], this in-
strument is considered too restricted for the purpose of
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this study. The remaining three instruments (CAFAS,
T-ASI and Euro-ADAD) were considered candidates
for use in CUA. One instrument (CAFAS) was consid-
ered slightly less suitable due to reasons of accessibility
(i.e. concerning a paid instrument as opposed to freely
available online versions of other instruments). For the
remaining two instruments (T-ASI and the Euro-ADAD)
only limited information on psychometric properties
could be obtained. It needs noting that the T-ASI and
Euro-ADAD are related as they are both based on the ASI
adult instrument [33, 43]. Psychometric properties of this
‘predecessor’ have been judged satisfactory [24, 49–52].
To our knowledge Euro-ADAD is more frequently used
in Europe, whereas T-ASI is more commonly used in
the United States.
Two psychometric studies with small sample sizes were
identified for the T-ASI [43, 53] and one study [33] with a
larger sample size was identified for the Euro-ADAD.
Frequency of use was slightly favorable for the T-ASI
compared to the Euro-ADAD as the instrument was
used four times in the studies identified in this systematic
review, whereas the Euro-ADAD was used in no more
than one study. These differences were not considered
sufficient to justify favoring either of the instruments over
the other. Hence, the T-ASI and Euro-ADAD were con-
sidered to have equal potential suitability for the compre-
hensive evaluation of systemic family interventions in a
health economic framework.
Discussion and conclusions
The objective of this systematic literature review was to
identify existing instruments in the field of adolescent
delinquency and substance use, which cover the relevant
domains of systemic family interventions. The instru-
ments were appraised based on characteristics relevant
for use in economic evaluations such as brevity, acces-
sibility, psychometric properties etc. Euro-ADAD and
T-ASI showed favorable characteristics in relation to
the criteria for a comprehensive outcome measure,
covering multiple relevant systems and being suitable
for obtaining preference weights. Both instruments lack
preference weights for the outcomes, at present. Attaining
these (as a potential next step) would facilitate calculating
‘utility scores’ as common in economic evaluations. Fur-
thermore, the results of the current study may inform fu-
ture efforts towards standardized and comprehensive core
outcome sets as defined by the COMET initiative [54].
The study may be seen as a preparatory step towards a full
COMET effort to standardizing the QALY approach to
include broader effects.
Some limitations of this study must be noted. First,
given our focus on published research up to 2013, we
may have missed out on very recent developments in
this field. In the Netherlands, for instance, a new, com-
prehensive instrument for measuring substance abuse in
adolescents is being developed, called the MATE-Y [55],
which includes nine modules each containing several do-
mains. Yet, up to today there have not yet been publica-
tions on the MATE in the field of youth/adolescents.
But similar developments may be ongoing elsewhere.
Second, we have not investigated the possibility of con-
structing a new measure by combining different mea-
sures into one composite measure. Though this may be
a limitation of this paper, we considered it a necessary
first step to identify the instruments currently available
in the field for direct use. This may also help to highlight
the relevant domains to include in a newly developed in-
strument. With our approach, we were able to identify
two instruments as most promising candidates to use in
comprehensive evaluations of systemic family interven-
tions. Neither instrument is currently considered ‘gold
standard’ in practice. Furthermore, as common for sys-
tematic reviews, the results from the current study are
based on a limited selection of databases within a limited
timeframe. Yet the number of screened and identified
articles was extensive and we assume that the consult-
ation of an even larger number of databases would not
have yielded significant differences in results. Also, the
characteristics for further selection of the instruments
were necessarily arbitrary and guided by our goal of
selecting one or more instruments suitable to be used to
attain societal preference weights and be used in eco-
nomic evaluations in the long term. We realize that the
suitability criterion of a maximum of 500 questions/1 h
of completion time may be rather high when considering
the busy clinical practice and ongoing evaluation of pa-
tient progress. Furthermore, had we considered different
or more broad characteristics, additional instruments
might have been found suitable. For example, one could
think of shortening existing longer instruments first and
then proceeding towards steps of attaining societal pref-
erence weights. In the light of limited time, this was not
considered feasible in the current study.
Table 5 Frequency of instrument use
Instrument name # of papers which
used this measure
Global Appraisal of Individual Needs (GAIN) 13
Teen Addiction Severity Index (T-ASI) 4
Adolescent Diagnostic Interview (ADI) 4
Problem Oriented Screening Instrument
for Teenagers (POSIT)
2
Child Adolescent Functional Assessment
Scale (CAFAS)
1
Washington Association of Juvenile
Court 6Administrators - Risk Assessment
(WAJCA-RA)
1
Adolescent Drug Abuse Diagnosis (Euro-ADAD) 1
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Notwithstanding these limitations, our review revealed
two promising, currently used instruments, which may
be made suitable for inclusion in economic evaluations
of systemic family interventions: the Euro-ADAD and
T-ASI. To make these instruments suitable for health
economic evaluations, first of all, more detailed investi-
gation is necessary of their validity, feasibility and com-
prehensiveness. Current information on this is scarce,
yet needed. Moreover, using these instruments in health
economic evaluations will require important next steps.
In particular, preference weights would need to be de-
rived for the different states described by the instru-
ment, like those available for health-related utility
measures such as the EQ-5D. This is possible through
preference elicitation techniques, such as discrete
choice experiments or time-trade-off techniques, ultim-
ately leading to ‘utility scores’, which can be attached to
the different ‘states’ described by the instrument.
Intriguing questions in this context relate to who
should indicate the state a person is in and who should
provide the values for the different possible states (i.e.,
whose preferences count). In line with many guidelines
for health-economic evaluations [11, 56], and in line
with the broad aim of systemic family interventions,
one could ask ‘patients’ to provide self-reports based on
one of the identified multidimensional instruments.
The value attached to this state could then be based on
preferences obtained in the general population. This
would provide ‘societal weights’ for the broad outcomes
of systemic family interventions. These societal weights
could thus be attached to the state a person indicates
him- or herself to be in on the multidimensional instru-
ment, thus leading to an overall utility score. Given the
broad range of outcomes, including effects incurred by
others than the patient or even his family (e.g., a safe
neighborhood), the score thus relates to a preference
ordering over states that include the effects on more
than the patient alone. This may be an additional rea-
son for opting for general public preferences. However,
whether the general public is the appropriate source
(rather than e.g. decision makers or health care profes-
sionals) must be further assessed and discussed, as well
as their ability to appropriately weight such diverse out-
comes. The more fundamental question is whether
these scores would count as ‘utilities’ or rather as
multi-criteria decision weights.
Other relevant issues in developing a multidimen-
sional utility measure of systemic family interventions
may be the diversity and hierarchy of treatment ef-
fects. As mentioned earlier, a comprehensive measure
would include health as well as non-health effects and
would also include both the effects on the patient
himself and society as a whole. Obviously, these differ-
ent effects may be interrelated. Moreover, some
observable effects may be considered to be intermedi-
ate effects, whereas others may be final outcomes. Re-
lated to this point, there may be short-term and long-
term effects, which can be important. Hence, in the
construction of such a preference-based measure,
good care needs to be taken of the possible interaction
of the effects.
One may argue that an alternative route to finding
an appropriate outcome measure could be to use exist-
ing measures in the field of economic evaluation, most
notably QALY measures. To our knowledge, so far
there have been only a few studies on the validity of
preference-weighted health-related quality of life in-
struments in an adult population of substance abusers
[57, 58]. There have been two studies on the degree to
which common preference-weighted measures of qual-
ity of life (e.g. QWB-SA, SF-12) correlate with sub-
stance use severity [58, 59]. Whereas the first study
provides evidence for insufficient coverage of all dis-
ease dimensions in substance use disorder [58], the
second study does suggest moderate to good correl-
ation between quality of life measures and substance
use severity measures [59]. In order to verify these re-
sults and determine whether the proposed instruments
add value in the field of delinquency and substance
abuse in adolescents, further research on the suitability
and potential of the quality adjusted life year (QALY)
measure in this population is recommended.
Keeping these alternatives in mind, further research
on the instruments highlighted in the current paper,
specifically on the attachment of societal preference
weights could bring evaluation of mental health inter-
ventions for delinquent and substance abusing adoles-
cents closer to the standard methodology in health
economic evaluations of curative medical interventions.
Both identified instruments appear suitable and broad
enough to capture the effects of family interventions in
substance abusing and delinquent adolescents in such
CUA. Adding societal preference weights to one of
these instruments will create an instrument, which
combines the advantage of the specificity of a disorder-
specific instrument with compliance with common
methodology of health economic evaluations and cap-
tures the broad effects relevant to mental health inter-
ventions. CUAs of these interventions can then be
performed based on a broad and specific measure that
includes several systems/dimensions and at the same
time acknowledges the relative value that society at-
taches to improvements in these diverse systems.
Though performing CUAs in the field of substance
abuse and delinquency in adolescents remains a chal-
lenging task, this paper attempted to contribute to con-
fronting one of the major issues in that context: finding
a suitable outcome measure.
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